World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-42gkzt
Date of registration: 14/02/2012
Primary sponsor: Universidade Nove de Julho - São Paulo, SP, Brazil
Public title: Action of low power laser on pain and quality of life and sleep in patients with fibromyalgia
Scientific title: Effect of low-level laser therapy on pain, quality of life and sleep in patients with fibromyalgia
Date of first enrolment: 01/03/2011
Target sample size: 36
Recruitment status: not yet recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-42gkzt/
Study type: 
Study design:  Therapeutic, parallel, two arms, double-blind, randomized clinical trial  
Countries of recruitment
Brazil
Contacts
Name: Paulo de Tarso  de Carvalho
Address:  Av. Dr. Adolfo Pinto, 109 - Barra Funda. 01504-001. São Paulo Brazil
Telephone: (11) 3665-9752.
Email: paulo.tarso@uninove.br
Affiliation:  Universidade Nove de Julho
Name: Paulo de Tarso  de Carvalho
Address:  Av. Dr. Adolfo Pinto, 109 - Barra Funda. 01504-001. São Paulo Brazil
Telephone: (11) 3665-9752.
Email: paulo.tarso@uninove.br
Affiliation:  Universidade Nove de Julho
Key inclusion & exclusion criteria
Inclusion criteria: A clinical diagnosis of fibromyalgia based on American College of Rheumatology criteria;
Cognitive level sufficient for understanding the procedures and following the instructions;
Agreement to participate in the study and the signing of a statement of informed consent after receiving clarifications regarding the objectives of the study.

Exclusion criteria: Psychiatric disorders, history of drug abuse or other behaviors that require intervention psychiatric medication;
Development of uncontrolled clinical situations that prevent participation in aerobic activities, for efforts or group activities;
History of epilepsy, seizures, heart disease and arrhythmias;
A pacemaker;
Presence of undiagnosed pain;
Pregnant women;
Patients with malignant tumors.


Age minimum: 0
Age maximum: 0Y
Gender: F
Health Condition(s) or Problem(s) studied
Fibromyalgia, Sleep Disorders, Pain, Quality of Life
C05.651.324
C10.886
I01.800
C10.597.617
Intervention(s)
In the 36 study participants, will be applied to laser therapy low power (TLBP) on an automated laser (Twin Laser - MM Optics, São Paulo) who possessed two identical points of application provided by the manufacturer, with an active tip (TLBP group) and the other placebo, which does not emit energy (control group), but both possess the buzzer and the light guide. The two groups with 18 patients in each will receive four times applications per week for a period of three weeks a total of twelve sections. Applications shall be made in a timely and direct contact between the tip and the patient's skin. However, only the group patients will receive an effective radiation energy density of 6 Jcm ². Both groups held after the applications an exercise program lasting 50 minutes, which will include a 10 minute warm up and stretching, 30 minutes of aerobic exercise on treadmill and 10 minutes of relaxation exercises and stretching three times a week, during the four weeks of the study. "
Primary Outcome(s)
Improvement in pain, assessed using the following instruments: visual analogue pain scale, McGill Pain Questionnaire and pressure algometry. It is expected that the group treated with low power laser presents significant reduction of pain intensity scale analogic visual and increased pain threshold force to the pressure in algometry and the lower frequency in the selection of pain descriptors in categories affective and sensory and psycho-emotional component in the responses obtained in the McGill Pain questionnaire
Secondary Outcome(s)
Improving quality of life and sleep, as assessed through the following instruments: test generic Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the specific Fibromyalgia Impact Questionnaire (FIQ), polysomnography, and questionnaire Berlin Epworth sleepiness scale.It is expected that the group treated with low-power laser shows improvement in overall quality of life as assessed by testing generic Medical Outcomes Study 36-Item and Short-Form Health Survey (SF-36) mainly in the items, which include scales related to functional capacity, physical, bodily pain, general health and vitality. In the questionnaire Fibromyalgia Impact Questionnaire (FIQ), is expected to improve the quality of life issues related to the functional capacity, employment status, psychological distress and physical symptoms. In the items related to sleep quality as polysomnography, the Berlin questionnaire and Epworth sleepiness scale is expected to improve the quality of sleep.
Secondary ID(s)
0421.0.241.000-11
474921
Source(s) of Monetary Support
CNPQ - Brazil
Secondary Sponsor(s)
Universidade Nove de Julho - São Paulo, SP, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history